Cargando…
Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells
Immune checkpoint blockade (ICB) immunotherapy increases antitumor immunity by blocking cytotoxic-T-lymphocyte-associated protein 4 (CTLA-4) or programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) and displays robust clinical responses in various cancers. However, ICB immunothera...
Autores principales: | Wang, Tingting, Zheng, Naisheng, Luo, Qin, Jiang, Li, He, Baokun, Yuan, Xiangliang, Shen, Lisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558076/ https://www.ncbi.nlm.nih.gov/pubmed/31214189 http://dx.doi.org/10.3389/fimmu.2019.01235 |
Ejemplares similares
-
Human Breast Milk Promotes the Immunomodulatory Function of Probiotic Lactobacillus reuteri DSM 17938 in the Neonatal Rat Intestine
por: Hoang, Thomas K, et al.
Publicado: (2019) -
Study and use of the probiotic Lactobacillus reuteri in pigs: a review
por: Hou, Chengli, et al.
Publicado: (2015) -
Evolutionary changes of an intestinal Lactobacillus reuteri during probiotic manufacture
por: López, Lázaro, et al.
Publicado: (2019) -
Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors
por: Jones, Sara E, et al.
Publicado: (2009) -
In vitro assessment of the effect of probiotic lactobacillus reuteri on peri-implantitis microflora
por: Mulla, Munaz, et al.
Publicado: (2021)